Immune stability is characterized by a balanced state that allows the immune system to combat infection, while avoiding unwanted adverse self-responses. The dysregulation of this balance in a wide number of diseases highlights the potential of therapeutics with the ability to break or restore immune stability. Heat Biologics is a clinical stage company within the NightHawk Biosciences ecosystem focused on developing first-in-class immunomodulators that shift this balance and have promise to realize the potential of the immune system to fight cancer and inflammatory disease.
